Clinical Reviews
Andrew M. Johnson
PhD
et al.
In this article, we look specifically at the burden experienced by caregivers of individuals with Parkinson's disease.
Andrew M. Johnson
PhD
et al.
The cluster of neuropsychiatric sequelae known as impulse-control disorders...
Amitabh Gupta
et al.
Progressive supranuclear palsy (PSP) is a rare, fatal neurodegenerative disease with limited treatment options that is characterized by gait and postural instability and a classical vertical supranuclear gaze palsy.
Shen-Yang Lim
et al.
Parkinson’s disease (PD) is characterized by the presence of bradykinesia, rigidity, and rest tremor.
Joel S. Hurwitz
This article will assist the clinician in defining and categorizing tremor, also suggesting key questions and physical examination techniques to facilitate a probable diagnosis in an older adult.
John R. Wherrett
Nonneurologist practitioners faced with the diagnosis of dementia cannot be expected to conduct the detailed assessments for which neurologists are trained.
Bhaskar Ghosh
et al.
Chorea is a hyperkinetic movement disorder characterized by nonsustained, rapid, and random contractions that may affect all body parts.
The Impact of Exercise Rehabilitation and Physical Activity on the Management of Parkinson’s Disease
A.M. Johnson
et al.
Although medication therapy is generally effective in the clinical management of Parkinson’s disease (PD), additional improvement of some gross motor symptoms may be achieved through the use of nonpharmacological treatments, such as physical therapy and exercise rehabilitation.
Alex Mihailidis
et al.
Mobility and independence are essential components of a high quality of life. Although they lack the strength to operate manual wheelchairs, most physically disabled older adults with cognitive impairment are also not permitted to use powered wheelchairs due to concerns about their safety.
Felix Geser
et al.
Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder characterized clinically by various combinations of parkinsonian, autonomic, cerebellar, or pyramidal signs and pathologically by cell loss, gliosis, and a-synuclein-positive glial cytoplasmic inclusions in several brain and spinal cord structures.









